Find creators, research, trials, and explainers.
Search community creators, the full library, daily briefings, and live source records in one place.
Juicebox Podcast
One of the largest T1D communities in the world. Scott Benner (dad of a T1D daughter) interviews people with T1D, parents, and clinicians — focused on practical diabetes management, Bold with Insulin, and the real-life nuances of living with T1D.
Beyond Type 1
Global nonprofit co-founded by Nick Jonas. Covers T1D advocacy, management, community stories, clinical trial access, and the T1D Tech Summit. One of the most active social communities for people with T1D.
Breakthrough T1D
The world's leading T1D research funder (formerly JDRF). Funds cure programs, clinical trials, and advocacy. Their YouTube and TikTok channels surface breakthroughs, trial updates, and researcher interviews.
Mastering Diabetes
A nutrition-focused education platform by two certified diabetes care educators who both live with T1D. They teach a low-fat, plant-based approach and have trained thousands of people to reduce insulin resistance. Note: their dietary approach is evidence-informed but not universally recommended — labeled as community/education, not clinical guidance.
diaTribe
Independent diabetes news and advocacy organization. Covers research, devices, policy, and living well with diabetes. Run by the diaTribe Foundation with journalists who live with or alongside diabetes.
T1D Exchange
A nonprofit research organization running the largest T1D patient registry in the US. Their Glu community platform and Quality Improvement Collaborative drive real-world outcomes data and improvements in clinical care.
Children with Diabetes (CWD)
Long-running online community for parents of children with T1D and adults with T1D. Hosts Friends for Life conferences, technology forums, and a large Q&A archive.
Transplanted Stem Cell Islets Show Promise in Early Mouse Studies—Here's What Matters
New research tracks how lab-grown insulin-producing cells mature after transplant and identifies key factors that influence their success. The findings could help improve future stem cell treatments for Type 1 diabetes.
Exploring Rare Breast Inflammation: What BRCA Mutations and Type 1 Diabetes May Share
Researchers are investigating possible links between hereditary breast cancer genes and a rare inflammatory breast condition historically tied to Type 1 diabetes. Understanding these connections may reveal new insights into autoimmune and genetic risk factors.
New Research Shows Continuous Glucose Monitoring Works Well During Pregnancy With Diabetes
A clinical trial found that a factory-calibrated CGM system accurately tracked blood sugar in pregnant women with gestational diabetes over two weeks. The findings support CGM as a helpful tool for managing glucose levels during pregnancy.
New Research Reveals How Immune Cells Go Wrong in Type 1 Diabetes
Scientists have discovered that regulatory T cells—the immune cells meant to protect the pancreas—become unstable and inflammatory in Type 1 diabetes. Understanding these changes could help researchers develop better therapies.
New Tool Helps Doctors Spot Caregiver Stress in Young Children With Type 1 Diabetes
A study shows that screening parents and guardians for diabetes-related stress is important—and that advanced insulin technology doesn't automatically reduce the emotional burden of managing a young child's care.
How Continuous Glucose Monitoring Can Help Older Adults With Diabetes Stay Healthier
New research shows that CGM technology reduces dangerous low blood sugar episodes and helps older people with diabetes maintain better overall health and independence.
Celiac Disease in French Children: What New Research Reveals
A comprehensive study of French health records shows celiac disease affects fewer children in France than in other European countries, but the condition remains an important screening consideration for Type 1 diabetes.
Closed-Loop Insulin Pumps Show Promise for Managing Type 1 Diabetes in Pregnancy
A new clinical trial found that closed-loop insulin systems help pregnant women with type 1 diabetes spend more time in safer blood sugar ranges. Here's what the research shows about this technology during pregnancy.
Remote Monitoring Cuts Clinic Visits in Half Without Compromising Blood Sugar Control
A real-world study shows that people using automated insulin pumps can receive effective care through telemonitoring instead of frequent in-person appointments. Blood sugar outcomes stayed the same while doctor visits dropped significantly.
Does an Automated Insulin Pump System Pay Off? What a Hong Kong Study Found
Researchers analyzed whether the MiniMed 780G automated insulin delivery system offers better value than traditional insulin injections plus glucose monitoring over decades. Here's what the data showed.
Study Finds Depression More Common in Type 1 Diabetes Than Type 2
A new research study from Kosovo reveals that people with Type 1 diabetes report higher levels of depressive symptoms than those with Type 2 diabetes. Understanding this mental health connection may help improve diabetes management and quality of life.
New Eye Technology Detects Subtle Blood Vessel Changes at Type 1 Diabetes Diagnosis
A study using advanced imaging found that children newly diagnosed with Type 1 diabetes show early changes in the small blood vessels in their eyes, even before any visible damage appears. This discovery could help doctors monitor eye health from the start of diagnosis.
Why Some Young People with Type 1 Diabetes Keep Making Insulin Years Later
A new study shows that about one-third of children with long-standing Type 1 diabetes still have working insulin-producing cells. Two factors—how much insulin was present at diagnosis and how long ago the diagnosis occurred—appear to be the strongest predictors of who keeps this residual function.
New Approach Uses Modified Stem Cells to Calm Immune Attack in Type 1 Diabetes
Researchers found that stem cells engineered to produce a specific immune-regulating protein delayed diabetes onset and protected insulin-producing cells in laboratory studies. The findings point to a potential new direction for immune-based therapies, though human testing is still needed.
What Really Drives People With Type 1 Diabetes to Move (or Rest)
A new study reveals that midlife adults with Type 1 diabetes experience conflicting motivations about exercise. Understanding these competing feelings—not willpower alone—may help people find movement that actually fits their lives.
Getting Care for Type 1 Diabetes: What Professionals Say Is Broken—and How to Fix It
A new study asked doctors, therapists, and social workers across Germany about caring for children with chronic conditions like Type 1 diabetes. What they found: the system is fragmented, hard to navigate, and leaves many families behind.
Scientists Engineer Stem Cell Islets to Survive the Immune System—Here's How
Researchers are using gene editing to create insulin-producing cells that can evade immune attack and withstand the stress of Type 1 diabetes. Early research suggests this approach could make stem cell transplants more durable.
New Trial Opens Islet Transplants to People with Type 1 Diabetes and Kidney Disease
A clinical trial is testing tegoprubart, a targeted immunotherapy, alongside islet cell transplants in people with type 1 diabetes who also have reduced kidney function—a group previously excluded from this treatment.
New Trial Opens Islet Cell Transplants to People with Type 1 Diabetes and Kidney Disease
For the first time, a clinical trial is testing islet cell transplantation in people living with both type 1 diabetes and chronic kidney disease. The study uses a gentler immunosuppressive drug designed to reduce kidney damage.
A New Blood Test May Help Catch Kidney Problems Early in Children with Type 1 Diabetes
Researchers are studying a protein called clusterin that appears in urine and could help doctors identify kidney damage before symptoms develop. Early detection could change how we monitor kidney health in young people with Type 1 diabetes.
How Automated Insulin Delivery Systems Are Changing Type 1 Diabetes Management
Recent research shows that automated insulin delivery systems help people with Type 1 diabetes spend more time in their target glucose range. Here's what the evidence reveals about how these systems work and who benefits most.
Managing Type 1 Diabetes in Very Young Children: What the Latest Research Shows
New technology and thoughtful care strategies are helping families of preschoolers with Type 1 diabetes achieve better blood sugar control and less worry. Here's what parents and caregivers need to know.
Maternal Diabetes During Pregnancy and Childhood Psoriasis Risk: What a New Study Found
A large Israeli study examined whether children born to mothers with diabetes during pregnancy face a higher risk of developing psoriasis. The findings may reassure expectant parents.
Why Beta Cells Matter: New Clues About Vulnerability in Type 1 Diabetes
Researchers have discovered that the structure and organization of insulin-producing cells in the pancreas play a key role in determining which cells are attacked first in Type 1 diabetes. Understanding these differences could help explain why the disease progresses differently in different people.
How Breakthrough T1D Brings Communities Together in the Fight Against Type 1 Diabetes
Breakthrough T1D is mobilizing support across North Texas through benefit walks and community gatherings. These events fund research and provide resources for families navigating Type 1 diabetes.
A New Tool for Ketone Monitoring: What the FDA Approval Means for Type 1 Diabetes
The FDA recently approved the first device that continuously monitors both glucose and ketones, offering people with Type 1 diabetes a new way to detect dangerous ketone levels early. Here's what you need to know.
Scientists Develop a More Stable Form of Glucagon to Treat Severe Low Blood Sugar
Researchers have created a new way to keep glucagon stable in liquid form for months at room temperature. This breakthrough could make it easier for people with Type 1 diabetes to treat dangerous low blood sugar episodes.
What New Pancreas Studies Reveal About How Type 1 Diabetes Develops
Researchers studying human pancreatic tissue are uncovering a more detailed picture of type 1 diabetes—one where insulin-producing cells begin to fail earlier and differently than once thought, and immune problems show up even before blood sugar rises.
New Framework Aims to Catch Type 1 Diabetes Earlier Through Screening
A national group of diabetes experts has developed practical guidance for identifying Type 1 diabetes in its earliest stages, before symptoms appear. Early detection opens the door to education, support, and potential disease-modifying treatments.
Reading the Metabolic Code: How Scientists Are Uncovering Type 1 Diabetes' Hidden Signals
New technology can detect metabolic changes in people with Type 1 diabetes, and sometimes even before symptoms appear. These discoveries could eventually help doctors diagnose the disease earlier and tailor treatments more precisely.
Scientists Engineer Vascularized Insulin-Producing Organoids That Survive Transplant and Restore Blood Sugar Control
A new approach to stem cell-derived pancreatic tissue addresses a major barrier to islet transplant success: poor survival after implantation. Researchers integrated blood vessel networks into lab-grown islets, improving their function and longevity in diabetic mice.
Closed-Loop Systems Show Promise for Pregnant People With Type 1 Diabetes
A new clinical trial found that automated insulin delivery systems help pregnant women with type 1 diabetes spend more time in healthy blood sugar ranges. This could reduce serious pregnancy complications that affect about half of all pregnant people with type 1 diabetes.
Low-Carb Eating Patterns May Lower Heart and Stroke Risk in Type 1 Diabetes
A new study from Japan suggests that adults with Type 1 diabetes who follow low-carbohydrate eating patterns—especially plant-based ones—had fewer heart attacks, strokes, and other serious cardiovascular events.
Spain Launches Framework for Earlier Type 1 Diabetes Detection Before Symptoms Appear
New clinical guidelines aim to identify people in the autoimmune stage of Type 1 diabetes years before they develop symptoms. The framework standardizes screening and monitoring to catch the disease earlier and improve long-term outcomes.
When Type 1 Diabetes and Celiac Disease Occur Together, Antibody Recovery Takes Longer
A new study shows that children diagnosed with both Type 1 diabetes and celiac disease take significantly longer for their celiac antibodies to return to normal levels compared to children with celiac disease alone.
How You Spend Your 24 Hours May Affect Blood Sugar Swings in Type 1 Diabetes
A new study suggests that shifting time between sleep, sitting, and activity levels could influence how stable your glucose readings stay throughout the day.
When Baby Screening for Type 1 Diabetes May Show False Positives: What Parents Should Know
New research reveals that antibody tests in infants can pick up maternal antibodies passed during pregnancy, potentially leading to unnecessary worry. Screening at a later age may give clearer answers.
New Study Maps Autoantibody Patterns in Adult-Onset Type 1 Diabetes
Researchers tracked autoantibodies in adults before Type 1 diabetes diagnosis, finding that detectable immune markers can appear decades earlier. The findings could help identify who is at risk.
How Anxiety and Sleep Shape Diabetes Self-Care in Teens
A new study reveals that anxiety and poor sleep quality are closely linked to how well adolescents manage their type 1 diabetes day-to-day. Understanding these connections may help teens and families find better support.
Genetic Testing Could Help Doctors Distinguish Type 1 Diabetes from Look-Alike Conditions
A new study shows that genetic risk scores may help clinicians more accurately diagnose Type 1 diabetes and identify who is at highest risk—especially important since Type 1 can be confused with other forms of diabetes.
Scientists Identify a B-Cell Marker That May Play a Role in Type 1 Diabetes
A new study points to CD180, a protein found on certain immune cells, as a key player in the autoimmune attack on insulin-producing cells. Researchers also explored whether a natural compound could modulate this immune response in the lab.
What Your Insulin Pump's Day-to-Day Patterns Can Tell You About Control
A new analysis of hybrid closed-loop systems reveals that how much an insulin pump's automated corrections vary from day to day may be just as important as the average amount of insulin it's delivering.
Can Mindfulness Help Teens Manage Type 1 Diabetes Better?
A new pilot study explored whether mindfulness training combined with diabetes education could help adolescents cope with the daily demands of Type 1 diabetes management.
Type 1 Diabetes and Mortality: What a Large Study Reveals About Modern Care
A major study tracking thousands of people with Type 1 diabetes found that while the condition does increase mortality risk, this risk has improved in recent years as diabetes care technologies have advanced.
What Single-Cell Science Is Revealing About Type 1 Diabetes and Other Autoimmune Diseases
New microscopic tools are helping researchers see immune cells in unprecedented detail, uncovering shared patterns across autoimmune diseases—and potential clues for better treatments.
Plant Oil Shows Promise in Lab Study of Type 1 Diabetes—What We Know So Far
Research in rats suggests that L. sativum oil may help preserve pancreatic function and improve blood sugar control in type 1 diabetes. The findings are preliminary and limited to animal models.
Immunotherapy Drug Pembrolizumab Linked to Rare but Serious Type 1 Diabetes
A review of 32 cases shows that pembrolizumab, a cancer immunotherapy, can trigger a severe form of Type 1 diabetes in some patients. Understanding the warning signs may help doctors catch this side effect early.
The Gut Microbiome and Type 1 Diabetes: What Probiotics Might—and Might Not—Do
Scientists are exploring whether probiotics can help prevent Type 1 diabetes by restoring balance to the gut bacteria. But a significant gap remains between laboratory promise and real-world results.
How Islet Size Shapes Cell Composition: What Scientists Found in Healthy Pancreases
A new study maps the relationship between islet size and the mix of insulin-producing and other hormone cells in human pancreases. The findings could help scientists design better artificial islets for transplantation in Type 1 diabetes.
SAB-142 Receives FDA Fast Track Designation for New-Onset Type 1 Diabetes
The experimental immunotherapy, designed to modify disease progression in newly diagnosed Type 1 diabetes, has been granted expedited FDA review status. The move reflects regulatory recognition of an unmet medical need in the Type 1 diabetes community.
Most Parents of Children With Type 1 Diabetes Experience Fear About Disease Progression—And It Matters
A new study shows that parental worry about T1D progression is common and connected to stress in both parents and children. Understanding this fear is an important part of family mental health.
How One Hospital is Using CGM Technology to Improve Insulin Dosing in Children
A new hospital policy shows that continuous glucose monitors can be safely used to guide insulin decisions in pediatric patients, with strong accuracy rates and nursing support. Here's what the program found.
Multiple Clinical Trials Now Recruiting for Type 1 Diabetes Research
Several investigational treatments are being tested in active studies across the Pacific Northwest and beyond. Here's what you need to know about participating in Type 1 diabetes research.
What Does Research Say About the Cost of Different Insulin Types?
A major review of global studies examines whether newer insulin analogues offer better value than traditional human insulins for adults with Type 1 diabetes.
New Stent Design Shows Promise for Delivering Insulin-Producing Cells in Type 1 Diabetes
Researchers have developed and tested a tiny stent that could one day carry pancreatic islet cells into the body to help regulate blood sugar. Early laboratory results show the device allows these cells to respond appropriately to glucose levels.
When Type 1 Diabetes Overlaps with Other Autoimmune Diseases: What New Research Shows
A new study finds that people with generalized myasthenia gravis who also have Type 1 diabetes or other autoimmune conditions may benefit from a specific treatment approach. Understanding these overlaps matters for better care.
When Standard Insulin Pumps Aren't Enough: One Man's Experience with U-500 and Automated Delivery
A new case study shows how one person with severe insulin resistance and Type 1 diabetes adapted an automated insulin pump system to work with a concentrated insulin. Here's what happened over a year of treatment.
Global T1D Research Community Convenes to Map Multiple Pathways Forward
The inaugural Breakthrough T1D Clinical & Research Congress brought together clinicians, scientists, and people with lived T1D experience to discuss advances across immunotherapy, technology, and islet cell approaches. Experts emphasized the importance of connecting research discoveries to real clinical care and patie…
Closing the Gap: New Approach to Making Diabetes Technology Accessible to All Young People
A UK study identified why some children and teens with Type 1 diabetes struggle to access modern technologies, then worked directly with patients and families to design solutions that work across different communities.
The Path to Beta-Cell Replacement: What Science Shows About Restoring Insulin Production
Researchers are working on ways to replace damaged insulin-producing cells through donor transplants and lab-grown alternatives. Early results show promise, but significant hurdles remain before these approaches become widely available.
Two Paths Forward: Researchers Debate Diabetes-Modifying Therapies vs. Islet Cell Transplants
At the inaugural Breakthrough T1D Clinical & Research Congress, leading experts weighed the tradeoffs between emerging disease-modifying treatments and cell-based approaches. Both show promise, but each comes with different practical challenges.
New Research Reveals Hypoglycemia Challenges for Adults Using Automated Insulin Delivery
A study of nearly 700 adults with Type 1 diabetes found that many people using automated insulin delivery systems still experience frequent low blood sugar events and take steps to avoid them.
What Fully Closed Loop Insulin Systems Could Mean for Type 1 Diabetes Management
Experts have created a shared definition of what next-generation automated insulin delivery should achieve. Here's what that means for the future of Type 1 care.
Closed-Loop Insulin Pumps Show Promise for Pregnant People with Type 1 Diabetes
A new clinical trial found that automated insulin delivery systems helped pregnant women with Type 1 diabetes spend more time in target blood sugar ranges. The findings suggest technology may reduce pregnancy complications tied to high blood sugar.
Closed-Loop Insulin Pumps Help Pregnant Women with Type 1 Diabetes Keep Blood Sugar Stable
New research shows that hybrid closed-loop systems—pumps that automatically adjust insulin doses—help pregnant women spend significantly more time in their target blood sugar range. This matters because stable glucose during pregnancy protects both mother and baby.
Islet Transplant Breakthrough: Tegoprubart Shows Promise as Immunosuppression Alternative
At the inaugural Breakthrough T1D Clinical & Research Congress, researchers presented encouraging early results from a clinical trial of tegoprubart, a new immunosuppressive approach for people receiving islet cell transplants.
Living Well With Diabetes Distress: Why Coping Skills Matter During the Teen Years
New research highlights an overlooked challenge for teens with Type 1 diabetes: about one in three experience significant distress that affects their health outcomes. Scientists are now exploring whether teaching young people to tolerate and manage this distress—not just eliminate it—could improve their long-term well…
How Ascorbic Acid and Exercise Affect Glucose Monitor Accuracy in Type 1 Diabetes
A new study examines whether vitamin C supplements and physical activity impact the precision of a continuous glucose monitor using GDH-FAD sensor technology. Understanding these factors may help you get more reliable readings from your device.
What Researchers Are Learning About Type 1 Diabetes and Oral Bacteria
A major review of 42 studies finds links between blood sugar control and changes in the bacteria living in your mouth. Here's what the evidence shows so far—and what questions remain.
New Tool Could Spot Islet Transplant Problems Before They Happen
Researchers have developed a way to monitor the immune system's response to transplanted insulin-producing cells, potentially catching rejection much earlier than current methods allow.
Could Continuous Glucose Monitoring Become a Tool for Earlier Diabetes Detection?
Researchers are exploring whether continuous glucose monitoring (CGM) devices could identify diabetes earlier than traditional blood tests. A new framework proposes how CGM might work alongside—or eventually replace—existing diagnostic methods.
What Determines Who Develops Type 1 Diabetes After Autoantibodies Appear?
A study of 7,000 real-world patients shows that age, blood sugar levels, and the number of diabetes-related autoantibodies are key predictors of progression from early autoimmunity to clinical Type 1 diabetes.
How Genetic Risk and Inflammation Disrupt Beta Cell Function in Type 1 Diabetes
New research reveals how Type 1 diabetes-linked genetic variants may directly damage the cells that make insulin by disrupting the molecular switches that control their function. Understanding these mechanisms could point toward better ways to identify and potentially prevent the disease.